Glaxosmithkline | GSK - Interest Expense On Debt

Stock Price
54.42
Daily Change
-4.70 -7.95%
Monthly
-8.17%
Yearly
45.39%
Q2 Forecast
53.52

Glaxosmithkline reported GBP177.95M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Amgen USD 653M 32M Dec/2025
AstraZeneca USD 484M 181M Dec/2025
Aurora Cannabis CAD 2.11M 116K Dec/2025
Bausch Health Companies USD 412M 53M Sep/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Canopy Growth CAD 7.34M 1.46M Dec/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Drreddys Laboratories INR 944M 127M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
Glaxosmithkline GBP 177.95M 6.05M Sep/2025
J&J USD 43M 25M Mar/2026
Merck USD 412M 85M Dec/2025
Novartis USD 304M 23M Dec/2025
Pacira USD 3.89M 387K Dec/2025
Perrigo USD 10.08B 10.04B Sep/2025
Pfizer USD 711M 59M Dec/2025
Phibro Animal Health USD 11.91M 191K Dec/2025
Prestige Brands USD 10.67M 636K Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 178M 203M Mar/2026
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Takeda JPY 123.63B 40.49B Dec/2025
Teva Pharmaceutical Industries USD 220M 17M Dec/2025
Zoetis USD 57M 1000K Dec/2025